Aloxi

Public company news  15 Jan 2006
Pioneer Press, MGI Pharma (Nasdaq: MOGN): Said 2005 sales of its Aloxi drug — an injection to treat chemotherapy-related nausea — totaled $248 million, below MGI's ...

MGI PHARMA Provides Corporate Update; 2005 Aloxi(R) Injection ...  Jan 10, 2006
Genetic Engineering News, ...-- Commercial products: Total sales of Aloxi(R) injection in 2005 increased 56% over 2004 sales of $159 million, primarily due to increased share in the ...

NWA gets extension to file reorganization plan  Jan 11, 2006
Pioneer Press, Bloomington-based MGI Pharma said Tuesday that sales of its Aloxi drug missed company guidance and predicted 2006 sales beneath Wall Street views. ...

MGI Pharma Still A 'Solid Company' Despite Mixed Guidance  Jan 11, 2006
Forbes MGI Pharma (nasdaq: MOGN - news - people ) to $24 from $30 after the company pre-announced slightly lower-than-expected fourth-quarter sales of Aloxi, its post ...

UPDATE 1-MGI Pharma 2006 revenue outlook below expectations  Jan 10, 2006
Reuters Unaudited figures showed that sales of Aloxi, the company's treatment for chemotherapy-induced nausea and vomiting, rose 56 percent in 2005 to $248 million ...

MGI Pharma provides '06 sales guidance  Jan 10, 2006
Twin Cities Business Journal, Sales of the company's Aloxi injection, a nausea drug, increased 56 percent to $248 million in 2005, including $67 million in the fourth quarter. ...

MGI Pharma "buy," target price reduced  Jan 12, 2006
New Ratings In a research note published yesterday, the analyst mentions that the company has recently pre-announced its sales results for Aloxi and Giladel below the ...

MGI Pharma "neutral"  Dec 27, 2005
New Ratings In a research note published this morning, the analysts mention that although the company witnessed robust Aloxi sequential sales growth of 43% in November ...

MGI PHARMA to Present at the JPMorgan Healthcare Conference  Dec 21, 2005
Genetic Engineering News, MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) injection and Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) in the United States. ...